CCEL Q1 2024 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q1 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+0.4% YoY

Gross Profit

$6M73.7% margin

Operating Income

$821,22310.5% margin

Net Income

$556,2417.1% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

-$356,865

Free Cash Flow

-$814,587

Stock-Based Comp.

$307,355

Balance Sheet

Total Assets

$62M

Total Liabilities

$72M

Stockholders' Equity

-$10M

Cash & Equivalents

$247,112

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+0.4%
Gross Profit	$6M	$6M	+0.5%
Operating Income	$821,223	$2M	-51.2%
Net Income	$556,241	$766,812	-27.5%

Revenue Segments

Processing And Storage Fees

$8M99%

Public Banking

$43,7131%

Product

$3,0000%